middle.news
Echo IQ Advances US Market Entry with FDA Nod and New CEO
6:47pm on Sunday 1st of June, 2025 AEST
•
Healthcare
Read Story
Echo IQ Advances US Market Entry with FDA Nod and New CEO
6:47pm on Sunday 1st of June, 2025 AEST
Key Points
FDA 510(k) clearance obtained for EchoSolv AS
Appointment of Dustin Haines as US-based CEO to lead commercialisation
Flagship deployment at Beth Israel Deaconess Medical Center
Identification of reimbursement code with potential US$100–150 fee-per-use
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Echoiq (ASX:EIQ)
OPEN ARTICLE